Title : Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir.

Pub. Date : 2019 Mar

PMID : 30906544






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir. daclatasvir proprotein convertase subtilisin/kexin type 9 Homo sapiens
2 In summary, treatment of HCV with Daclatasvir/Asunaprevir resulted in elevated LDL, and relative miR122 and PCSK9-A levels in serum appeared to have some association with LDL increase. daclatasvir proprotein convertase subtilisin/kexin type 9 Homo sapiens